About
About SciClone Pharmaceuticals (Holdings) Limited
OneRobotics (Shenzhen) Co., Ltd. designs, develops, manufactures, and sells home robotics system products and other home robot products and accessories in Japan, Europe, North America, and rest of the world. The company develops SwitchBot App that enables users to achieve centralized control of home robotic system products for intelligent home living experience. It offers dexterous hand-mimic robots, such as lock robots, curtain robots and finger robots, and enhanced mobile robots, such as multitasking household robots, and sports robots; perception and decision-making systems, including smart hubs, smart sensors, and smart cameras; and other smart home products and services, such as light tools, power tools, and smart home appliances under the SwitchBot and Acemate brand names. The company also provides various accessories, including cleaning supplies, power solutions, smart home control accessories, and security add-ons; and cloud storage services to utilize digital archiving for footage captured by its smart cameras. Its products are used in home automation, domestic chores, AI butler, elderly care, security, and energy management applications. The company sells its products to end consumers, retailers, and distributors. The company was founded in 2015 and is headquartered in Shenzhen, China.
Research context
SciClone Pharmaceuticals (Holdings) Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Technology
- Industry
- Computer Hardware
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
From a valuation standpoint, the stock is 95.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Based on the above factors, Sciclone Pharms (Hldg) Ltd gets an overall score of 1/5.